The University of Southern Mississippi

The Aquila Digital Community
Faculty Publications
4-11-2018

High Male Sexual Investment As a Driver of Extinction in Fossil
Ostracods
Maria João Fernandes Martins
Smithsonian Institution

T. Markham Puckett
University of Southern Mississippi, Mark.Puckett@usm.edu

Rowan Lockwood
College of William and Mary, rxlock@wm.edu

John P. Swaddle
College of William and Mary, jpswad@wm.edu

Gene Hunt
Smithsonian Institution

Follow this and additional works at: https://aquila.usm.edu/fac_pubs
Part of the Biology Commons

Recommended Citation
Martins, M. J., Puckett, T., Lockwood, R., Swaddle, J. P., Hunt, G. (2018). High Male Sexual Investment As a
Driver of Extinction in Fossil Ostracods. Nature: International Journal of Science, 556, 366-369.
Available at: https://aquila.usm.edu/fac_pubs/16616

This Article is brought to you for free and open access by The Aquila Digital Community. It has been accepted for
inclusion in Faculty Publications by an authorized administrator of The Aquila Digital Community. For more
information, please contact Joshua.Cromwell@usm.edu.

HHS Public Access
Author manuscript
Author Manuscript

Nature. Author manuscript; available in PMC 2019 November 01.
Published in final edited form as:
Nature. 2019 May ; 569(7755): 222–228. doi:10.1038/s41586-019-1104-8.

The bone marrow microenvironment at single-cell resolution
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Summary

Author Manuscript

The molecular complexity of the bone marrow (BM) microenvironment and its response to stress
are incompletely understood, despite its key role in the regulation of hematopoiesis. Here we map
the transcriptional landscape of BM vascular, perivascular, and osteoblast niche populations at
single-cell resolution at both homeostasis and under stress hematopoiesis. This analysis revealed a
previously unappreciated level of cellular heterogeneity within the BM niche, identified novel
cellular subsets, and resolved cellular sources of pro-hematopoietic growth factors, chemokines,
and membrane-bound ligands. Under conditions of stress, our studies revealed a significant
transcriptional remodeling of these niche elements, including an adipocytic skewing of the
perivascular cells. Among the stress-induced changes, we observed that vascular Notch ligand
delta-like ligands (Dll1,4) were downregulated. In the absence of vascular Dll4, hematopoietic
stem cells (HSC) prematurely induced a myeloid transcriptional program. These findings refine
our understanding of the cellular architecture of the BM niche, reveal a dynamic and
heterogeneous molecular landscape that is highly sensitive to stress, and illustrate the utility of
single cell transcriptomic data in systematically evaluating the regulation of hematopoiesis by
discrete niche populations.

Introduction

Author Manuscript

Hematopoiesis, the process of generating mature blood cells, is vital to carry out a variety of
functions such as oxygen transport, immune defense, and tissue remodeling. This
considerable undertaking is sustained by a rare population of self-renewing hematopoietic
stem cells (HSCs), maintained in a specialized BM microenvironment composed of leptin
receptor positive (LepR+) mesenchymal stromal cells and vascular endothelial cells1,2.
Osteoblasts have been proposed to support early lymphoid progenitor survival and
commitment3,4. Additional signals provided by sympathetic nerve fibers5,6, macrophages7,
megakaryocytes8, and non-myelinating Schwann cells9 also contribute to the HSC niche.
Accumulating studies suggest further degree of cellular complexity of BM architecture,
mediated through heterogeneity within vascular10 and mesenchymal stem and progenitor
cells (MSPCs)11,12.

Author Manuscript

Hematopoiesis has to be controlled in a precise and rapid manner to meet the varying
demands of homeostatic and stress conditions. Although our understanding of the BM niche
has significantly evolved over the past decade, studies addressing the molecular
heterogeneity and functional plasticity of the BM microenvironment have been limited,
largely due to low frequencies of these populations in the BM and the technical challenges
associated with their isolation. Here, by profiling 17,374 single BM niche cells, we identify
previously unrecognized heterogeneity within the BM microenvironment and demonstrate
how the microenvironment responds to acute BM stress at a single-cell level. We couple
transcriptional profiling with novel fluorescent reporters and functional studies to
demonstrate that vascular expression of the Notch receptor Dll4, identified by our single cell
studies, suppresses premature upregulation of the myeloid program in HSCs.
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Results
Transcriptomic profiling of the BM niche at single cell resolution
To reliably label the major BM niche subsets (Fig. 1a), we used lineage-specific Cretransgenic mice crossed to a “knock-in” reporter strain, in which tdTomato is preceded by a
“floxed” transcriptional stop at the Rosa26 locus (LoxP-tdTomato). VEcad-cre; LoxPtdTomato (VEcad-tdT) model labeled vasculature, the Lepr-cre;LoxP-tdTomato (Lepr-tdT)
marked LepR+ cells, and Col2.3-cre;LoxP-tdTomato (Col2.3-tdT) traced osteoblasts
(Extended Data Fig. 1a). Reporter BM was enzymatic digested, CD45/Ter119lotdTomato+
cells isolated (Extended Data Fig. 1b), and bulk mRNA sequencing (RNA-Seq) performed,
confirming the presence of transcriptionally distinct populations (Extended Data Fig. 1c, d).

Author Manuscript

To study the transcriptomic diversity of BM niche populations, we conducted single-cell
RNA-Seq (scRNA-Seq) of VEcad+, LepR+, and Col2.3+ cells. We compared cells sorted
from mice at steady-state and following acute stress induced by intraperitoneal 5-FU
administration (Extended Data Fig. 2a). BM niche cells were isolated, mRNA libraries
prepared (10x Genomics) and sequenced. Following quality filtering (see Methods), data
was obtained for 18,339 cells. To correct for the observed batch effects between independent
experiments (non-treated and PBS/5-FU treated), we used an “alignment” method13 based
on the canonical correlation analysis (CCA) (see Methods). The t-distributed stochastic
neighbor embedding (tSNE) and graph-based clustering were employed to investigate
cellular heterogeneity within the niche subsets. We removed 965 contaminating, mostly
hematopoietic, cells and used the remaining 17,374 cells for the analysis (see Methods) (Fig.
3a, b).
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To examine the baseline transcriptome of the BM niche, we surveyed only the cells under
steady state conditions (n=9,622). Expression of genes associated with tissue-specific Cre
expression (Cdh5, Lepr, and Colla1) confirmed a clear separation of input niche populations
(Fig. 1b). We identified 2 endothelial, 4 perivascular, and 3 osteolineage subpopulations, as
well as a small (n=70) proliferating cell cluster (Figs. 1c–d, Extended Data Fig. 1e). Our
data is available for further exploration of cellular heterogeneity (http://aifantislab.com/
niche). As the goal of our study was to broadly define BM niche architecture, we focused on
the largest subpopulations.
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Two major clusters were identified within the BM vasculature using integrated (Figs. 1d, 2a)
as well as independent approaches (Extended Data Figs. 2b–d). To determine biomarkers for
each subpopulation, pair-wise differential expression analysis for each cluster against all
other clusters was performed. Branched networks of sinusoidal capillaries constitute the
majority of blood vessels in the bone marrow, whereas the arteries contain comparably few
side branches and are longitudinally aligned along the diaphysis14. Arterial-associated genes
were expressed in cluster V1 (Ly6ahigh; orange) and sinusoidal signature were specific to
cluster V2 (Stab2high; blue) (Extended Data Fig. 3a)15. We performed BM
immunofluorescence (IF), confirming arterial Sca1 (Ly6a), CD102Icam2) and Podxl (Podxl)
expression (Extended Data Fig. 3b, c) and sinusoidal expression of Vegfr316 (Flt4) and
CD54 (Icam1) (Extended Data Fig. 3d). Lama1 staining was used to specifically label BM
vessels17. In agreement with expression data, flow cytometry analysis allowed arterial
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identification by combining surface markers Sca1 (Ly6a), CD34 (Cd34) and Ly6C (Ly6c1)
(Extended Data Fig. 3e).
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The heterogeneity of the LepR+ compartment has been an open question in light of its
multilineage differentiation potential and mesenchymal stem cell (MSC) activity, as assayed
by formation of fibroblastic colony-forming units (CFU-F)18. Integrated analysis identified
four clusters within the LepR+ compartment (Figs. 1c, d, 2b). Clusters P1 (Mgphigh; red) and
especially P2 (Lplhigh; green) expressed adipogenesis-associated markers (Fig. 2b, Extended
Data Fig. 4a). Analysis of the LepR+ population alone confirmed clusters P1, P3 and P4
(Extended Data Fig. 2 e–g). Integrated analysis in the context of stress hematopoiesis
revealed an additional P2 cluster (Figs. 1d, 3b), suggesting a poised pro-adipogenic state,
rather than distinct progenitors. To validate potential biomarkers, we performed IF of LeprtdT femurs and found the sinusoidal capillaries covered with LepR+Esm1+ cells (specific to
P1 and P2), whereas metaphysis and endosteum capillaries were LepR+Esm1− (Extended
Data Fig. 4b). Clusters P3 (Wif1high; brown) and P4 (Spp1highIbsphigh; orchid) represented
osteo-primed LepR+ cells as they expressed progressively increasing levels of osteogenesisassociated genes (Fig. 2e). LepR+ cells expressing P3/P4 specific markers CD200 (Cd200)
and CD63 (Cd63) localized mainly to the trabecular portion of the bone (Extended Data Fig.
4c), consistent with their osteogenic signature. We detected high correlation between the
human MSC gene signature of hCD45− CD271+ BM cells19 and clusters P1/P2 (Extended
Data Fig. 4d). To functionally test in vitro stem cell capacity, we used surface markers to
prospectively isolate LepR+ cells (Extended Data Fig. 4e). Adipocyte-biased P1/P2
(Vcam1highCD63low) populations were significantly enriched in CFU-F and accounted for
the majority of CFU-F activity of the total LepR+ cells (Extended Data Fig. 4f).

Author Manuscript
Author Manuscript

The Col2.3+ cells were transcriptionally split into three populations (Figs. 1c, d, 2c). Cluster
O1 (Col16a1highTnnhigh; gray) expressed high levels of osteocrin (Ostn), angiopoietin like 2
(Angptl2), as well as Del-1 (Edil3) that has been recently shown to regulate myelopoiesis20
(Extended Data Fig. 5a). IF analysis of Col2.3-tdT femurs confirmed a subset of cells that
co-expressed O1 marker Mmp14 (Mmp14) with tdTomato in the epiphysis (Extended Data
Fig. 5b). Cluster O2 (Fbn1high/gf1high; moss) expressed osteogenic as well as chondrocytespecific genes (Extended Data Fig. 5a). As it has been previously reported that hypertrophic
chondrocytes co-express Col10a1 with markers of osteoblastic differentiation21, cluster O2
potentially represents cells undergoing osteogenic transdifferentiation (Fig. 1d, Extended
Data Fig. 5a). Consistently, BM IF confirmed co-expression of O2-associated marker CD9
(Cd9) with tdTomato in the epiphysis (Extended Data Fig. 5c). Cluster O3
(BglaphighCar3high; olive) represented mature osteoblasts based on the highest expression of
Col2.3 (Col1a1) and osteogenesis-associated genes (Fig. 2c, Extended Data Fig. 5a). BM IF
confirmed co-staining of tdTomato with the biomarker Car3 (Car3) (Extended Data Fig. 5d).
Additional smaller clusters were revealed through examination of the Col2.3+ subset alone.
Notably, aside from O1-O3 subsets, Col1a1 was expressed in vascular endothelial (C4), glial
(C5), and stromal-like (C6) cells (Extended Data Fig. 2h–j).
BM LepR+ cells give rise to both osteoblasts and adipocytes11. As tSNE visualization does
not maintain global structure of differentiation dynamics, we reconstructed the
developmental trajectory to infer the relationship between LepR+ P1-P4 cells and terminally
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differentiated osteo populations (Fig. 2d). Pseudotime ordering revealed a transcriptional
continuum of LepR+ cellular states, with known adipogenic and osteogenic markers rising
towards the opposite ends of this range (P1/P2 vs. P3/P4) (Fig. 2e).
To search for proliferating cells in the BM niche, we assessed cell-cycle associated genes,
such as Mki67 and found them confined to cluster C (magenta) (Fig. 1d, Extended Data Fig.
5e, f), comprised of all three examined niche populations (Extended Data Fig. 5g). This
confirms that at steady state, the majority (>99%) of adult BM niche cells are not actively
cycling. Collectively, these studies provide a detailed single-cell resolution map of the steady
state quiescent BM microenvironment, allowing us to reveal cellular heterogeneity within
each examined subset.
Single-cell profiling of BM niche-expressed factors able to regulate hematopoiesis
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We next examined expression patterns of pro-hematopoietic factors22 (Fig. 2f). We found
that the vascular cells expressed the highest levels of angiogenin (Ang), delta-like Notch
ligands (Dll4 and Dll1), and selectin E (Sele)23. Notably, within the vascular subset, arterial
cluster V1 was enriched in SDF-1 (Cxcl12) and SCF (Kitl)15. LepR+ clusters P1 and P2, in
addition to expressing the highest levels of SDF-1 (Cxcl12), SCF (Kitl) and IL-7 (Il7)24, also
represented a major source of IL-15 (Il15)25, IL-34 (Il34), M-CSF (Csf1), BMP-4 (Bmp4)26
as well as lymphocyte chemoattractant Ccl-19 (Ccl19) and monocyte chemoattractant Ccl-2
(Ccl2)27, indicating that adipocytic-primed LepR+ cells represent a major reservoir of prohematopoietic factors in the BM niche. Finally, the Col2.3+ cluster O1 expressed Wnt5a
(Wnt5a), previously demonstrated to maintain HSC quiescence28, while cluster O2
represented the primary source of Igf-1 (Igf1), a critical factor in hematological
malignancies29 and B cell development30. Through the enhanced resolution afforded by
scRNA-Seq, we were able to precisely define the cellular source and outline a distribution of
pro-hematopoietic factors within the defined niche sub-populations.
Single-cell RNA-sequencing profiling of the BM niche in response to stress

Author Manuscript

Chemotherapy, frequently used for the treatment of leukemia, results in the ablation of
rapidly dividing hematopoietic progenitor cells and induction of proliferation and
differentiation of otherwise quiescent HSCs31. Myeloablation affects sinusoidal vessels32 as
well as stromal cells and causes an increase in the frequency of the BM adipocytes33. To
assess the dynamic molecular and morphological changes of the BM niche under acute
stress conditions, we administered a single dose of 5-fluorouracil (5-FU; 150mg kg−1)34. By
day 5 (d5) following treatment, we detected a significant loss in BM cellularity, total counts
of BM Lineage−Sca-1+CD117+ (LSK) cells as well as BM vascular and perivascular
populations (Extended Data Figs. 6a–c).
To track gene expression changes in the BM niche during stress hematopoiesis, we profiled
7,752 cells post 5-FU treatment (Fig. 3a). Our results revealed the formation of a novel
adipo-primed cluster (P5, n=161; burnt orange) (Fig. 3b, Extended Fig. 6d) and a shift in
cluster contribution throughout LepR+ and Col2.3+ populations (Fig. 3c). Specifically, LepR
+ cells underwent significant transcriptional reprogramming through the expansion of adipoprimed cluster P2. Overall, upon 5-FU treatment, we observed a significantly upregulation
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of adipogenesis-related pathways and a global reduction in osteolineage-associated gene
expression (Extended Data Figs. 6e, f). Two independent scRNA-seq experiments on VEcad
+ and LepR+ populations showed comparable responses to 5-FU treatment, with a
correlation coefficient of r=0.63 for vascular and r=0.88 for LepR+ population for
significantly altered genes, indicating comparable association between experiments
(Extended Data Fig. 7). These results are consistent with the previously reported expansion
of adipocytes following bone marrow insult11,12.
An additional response to stress was an increase in cell proliferation across the niche
subsets. Following myeloablation, 5.4% of cells were in the cycling cell cluster as compared
to 0.7% at steady state (Extended Data Figs. 6g, h), potentially indicating initiation of a
regeneration process.

Author Manuscript

We next examined 5-FU mediated changes of pro-hematopoietic factors (Fig. 3d). We
detected upregulation of vascular Ang, perivascular Il7 and Bmp4, and osteo Wnt5a, as well
as downregulation of vascular Notch Delta ligands, Dll4 and Dll1, adhesion molecule Sele
and perivascular Wnt4, indicating changes in signaling strength of key pathways such as
Wnt and Notch. Collectively, our studies define considerable molecular reprogramming of
the BM microenvironment in response to chemotherapy.
Vascular endothelial niche cells represent the major source of Notch ligands Dll4 and Dll1
in the BM

Author Manuscript

Our analysis revealed that the Notch ligands Dll1 and Dll4 are specifically expressed in the
VEcad+ cells (Fig. 2f). RT-PCR analysis confirmed high expression of Dll1 and Dll4 in the
vascular endothelial subset compared to perivascular and osteolineage cells, whereas Jag1
expression was lower and comparable throughout vascular and perivascular populations
(Extended Fig. 8a). Moreover, Dll1 and Dll4 expression was dynamically downregulated in
response to stress (Fig. 3d). Targeting Notch receptor signaling in hematopoietic cells
previously established critical roles of this pathway in normal hematopoiesis. However, the
identity and roles of specific Notch ligands throughout the BM remain unclear35,36, with the
notable exception of Jag1, recently found to support HSC self-renewal37.
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To further map the BM Notch ligand expression, we generated Bacterial Artificial
Chromosome (BAC) - carrying transgenic reporter mice co-expressing individual Notch
ligands - Dll1, Dll4 or Jag1 – and the fluorescence marker mCherry (Fig. 4a). Using
fluorescence microscopy, we observed Dll4 and Dll1 expression throughout the cortical
thymic epithelium38,39 and Jag1 expression within the thymic medulla40, consistent with
previously published observations (Extended Fig. 8b). Flow cytometric analysis of the BM
CD144+ (VE-cadherin) vascular population within individual Notch ligand reporter strains
confirmed high vascular endothelial expression of Dll4 and intermediate levels of Dll1
expression (Fig. 4b, Extended Data Figs. 8c, d). In vivo two-photon imaging and IF of Dll4mCherry bones confirmed expression of Dll4 throughout the BM vascular compartment
(Fig. 4c, Extended Data Figs. 8e, g). Dll1 was additionally expressed in a subset of NK1.1+
hematopoietic cells (Fig. 4d, Extended Data Figs. 8f–j). Collectively, this data provides a
comprehensive map of Dll4 and Dll1 expression throughout the BM.
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To further investigate a putative role of vascular Dll4 in normal hematopoiesis, we assessed
the impact of vascular endothelial-specific deletion of Dll4. We crossed a vascular-specific,
tamoxifen-inducible Cre strain (Cdh5-CreERT2) to mice harboring a conditional Dll4 lossof-function allele (Dll4i3COIN), termed VEc-Dll4i3COIN. Following Dll4 deletion throughout
the VEcad+ vascular compartment, we detected a decrease in the frequency of Lin
−Sca-1lowCD117lowFlt3+IL7Rα+ common lymphoid progenitors (CLPs) and an expansion
of myeloid progenitor populations within the Lin−Sca-1−CD117+FcγR+CD34+ gate (GMPgate), previously reported to contain mixed-lineage myeloid potential41–43 (Extended Data
Fig. 9a,b). Accordingly, we observed a loss of B220+ B cell and CD3+ T cell lymphoid
populations and an expansion of the myeloid Gr1+CD11b+ compartment in VEc-Dll4i3COIN
animals (Figs. 5a–c, Extended Data Fig. 9c, d). Interestingly, despite the loss of CLP cells,
the deletion of vascular Dll4 did not affect frequencies or numbers of Lin
−CD117+Sca-1+CD135+IL7Rα− lymphoid-primed multipotent progenitors (MPP4/
LMPP)44, considered to be upstream of the CLP subset (Extended Data Fig. 9h, i).
Consistent with the loss of early lymphoid progenitors, we observed a significant loss of the
thymic cellularity in VEc-Dll4i3COIN animals and decrease in numbers of early thymic
progenitors (ETP: CD4−CD8−CD25−CD44+CD117+), but no evidence of specific
developmental blocks in thymocyte differentiation (Extended Data Figs. 9e–g).
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We detected no significant alterations in frequencies or numbers of phenotypic LT-HSCs
(Lin− CD117+Sca-1+CD150+CD48−) or multipotent progenitors (MPP2: Lin
−CD117+Sca-1+CD150+CD48+ and MPP¾: Lin−CD117+Sca-1+CD150−CD48+) in the
absence of vascular Dll4 (Extended Data Fig. 9h, i). IF analysis confirmed localization of
CD150+Lin− hematopoietic stem progenitor cells (HSPCs) in the proximity of vasculature45
in mDll4-mCherry animals (Extended Data Fig. 9j). To further define the impact of vascular
Dll4 deletion on the HSPC population, we performed scRNA-seq on HSPCs from control
and VEc-Dll4i3COIN animals. Following quality controls (see Methods), we profiled 21,116
HSPCs (Extended Data Fig. 9k). To assign cells to specific HSPC subsets (HSCs, MPP2–4),
we scored individual cells by calculating a module score based on the average expression
levels of the previously reported population-specific gene signatures46 (Fig. 5e). Our
analysis revealed a premature upregulation of the myeloid gene expression program47 as
early as the HSC stage, further preserved in all consecutive progenitor populations and a
reduction of HSC enrichment (Extended Data Fig. 9l, m). Well-established myeloidassociated genes were ectopically overexpressed across all HSPC subsets (Fig. 5f). These
results demonstrate a complete rewiring of the hematopoietic lineage commitment in the
absence of the vascular Dll4, leading to a significant myeloid bias of all HSPC fractions and
providing a molecular explanation for the phenotype of the VEc-Dll4i3COIN animals.
Finally, we assessed the role of vascular endothelial-specific Dll1 deletion on normal
hematopoiesis, by combining Dll1-floxed alleles (Dll1fl/fl) and VEcad-Cre to generate ECspecific loss-of-function mice (VEc-Dll1fl/fl). We found no alterations in hematopoietic
differentiation (Extended Data Fig. 10). Taken together, these results indicate that vascular
Dll4, but not Dll1, is a key Notch ligand controlling early hematopoietic differentiation
potential.
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Discussion
A growing body of evidence proposes a departure from the traditional hierarchical model of
hematopoiesis, suggesting instead a fluidity in the ability of each HSC to differentiate
towards distinct lineages48. It is tempting to hypothesize that such plasticity is dictated by
unique interactions between HSCs and the components of the microenvironment. Our results
expand the understanding of the BM niche by presenting a detailed transcriptional blueprint
of distinct vascular, perivascular, and osteolineage BM niche components.

Author Manuscript

Here we show that single-cell transcriptomic profiling can translate to novel mechanistic
insights into the regulation of stem/progenitor cell differentiation. We match hematopoietic
factors to their cellular sources and show that the loss of vascular endothelial-expressed
Notch ligand Dll4 skews BM hematopoiesis toward a significant transcriptional
reprogramming and myeloid priming of HSPCs. Future studies should investigate the
functional consequences of niche heterogeneity on aberrant stem cell functions, such as
immunodeficiency, hematopoietic malignancies, and aging. Targeting niche-associated
factors could interfere with the disease initiation and progression, as it was recently shown
by targeting vascular Cxcr4:Cxcl12 interactions in acute lymphoblastic leukemia49,50.

Methods
Animals.
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B6.FVB-Tg(Cdh5-cre)7Mlia/J (VEcad-Cre)51, B6.129-Leprtm2(cre)Rck/J (Lepr-Cre)52, and
B6.Cg-Tg(Col1a1-cre/ERT2)1Crm/J (Col2.3-cre)53, and B6.Cg-Gt(ROSA)26Sortm9(CAGtdTomato)Hze/J (Rosa26-tdTomato) mice were from Jackson Laboratory54. B6.CBATg(Cdh5-cre/ERT2)1Rha was kindly provided by Ralf H. Adams (Max Planck). Dll4i3COIN
model was provided by Aris Economides55. Dll1fl/fl animals were previously described56. To
generate the full-length BAC transgenes, we used C57BL/6 (B6) mouse genomic BAC clone
RP23–46P4 (mDll4), RP23–113N21 (mDll1) and RP23–19018 (mJag1) obtained from the
Children’s Hospital Oakland Research Institute (CHORI) repository and modified by
recombination in bacteria as described57. The cassette containing mCherry cDNA, polyA
signal and FRT-flanked bacterial zeocin resistance gene (ZeoR)58 was recombined into the
first exon, and ZeoR was removed by FLP-mediated recombination. BAC transgenes were
digested with Notl and injected into fertilized oocytes of (B6xDBA2)F1 hybrid mice or pure
inbred B6 mice.
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To induce Cre-mediated gene inactivation, animals were injected with 1,000μg tamoxifen
(Sigma, T5648) intraperitoneally every day for 5 days. All mice were rested for 14 days
before subjecting them to a second round of 5 tamoxifen injections. Animals were analyzed
1–3 months following tamoxifen injection. Both male and female sex-matched littermate
controls were used for all studies. For 5-FU treatments, mice were injected intraperitoneally
once with 150mg kg-1 5-FU (Sigma-Aldrich, F6627–5G) or PBS. All 5-FU-injected animals
were screened for efficient myeloablation by BM cellularity measurement. All animal
experiments were performed in accordance with protocols approved by the New York
University Institutional Animal Care and Use Committee.
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Flow cytometry.
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BM cells were isolated by flushing the long bones in PBS with 2% fetal bovine serum on
ice. Single-cell suspensions of thymus and spleen were obtained by gentle tweezing of the
organs with forceps. The cells were dissociated to a single-cell suspension by filtering
through a 70μm nylon mesh. Nonspecific antibody binding was blocked by incubation with
2.4G2. Cells were incubated with primary antibodies for 60 min and streptavidin conjugates,
when applicable, for 15 min on ice.
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All antibodies were purchased from BD-Pharmingen or e-Bioscience. We used the following
fluorochrome or biotin conjugated antibodies: CD117 (2B8), Sca-1 (D7), CD11b (M1/70),
Gr-1 (RB6–8C5), NK1.1 (PK136), TER-119, CD3 (145–2C11), CD127 (A7R34), CD34
(RAM34), FcγRII/III (2.4G2 or 93), CD135 (A2F10.1), CD4 (RM4–5), CD8 (53–6.7),
CD150 (9D1), B220 (RA3–6B2), CD48 (HM481). BM lineage antibody cocktail included
CD11b, Gr-1, NK1.1, TER-119, CD4, CD8, B220.
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For flow cytometric analysis of VEcad-cre;LoxP-tdTomato and Lepr-cre;LoxP-tdTomato,
the whole BM (two femurs, two tibias, and two ileums) was flushed and digested with
LiberaseTM (0.2 mg/ml)) and DNase I (200U/ml) at 37°C for 60min at 550 rpm shaking
with additional mixing the cells every 10 min with pipetting. For flow cytometric analysis of
Col2.3-cre;LoxP-tdTomato, the animals were first injected with 1,000μg tamoxifen (Sigma,
T5648) intraperitoneally three times and were processed two weeks following the last
injection. Two weeks following the last injections femurs, tibias, and ileums were isolated,
cut into 2mm pieces and digested with LiberaseTM and DNase I at 37°C for 90min at 550
rpm shaking with additional mixing the cells every 10 min. Following digestion, the cells
were placed on ice and the reaction was quenched with FACS buffer with 1% 0.5M EDTA
(Fisher Bioreagents).
For analysis of BM endothelial cells, mice were i.v. injected with 10ug/mouse eFluor660
conjugated anti-VE-cadherin antibody (BV13, eFluor 660, eBioscience). Fifteen minutes
later, the animals were euthanized, the long bones were removed, and BM was flushed,
digested and stained as above. Data were analyzed by FACSDiva (BD) or FlowJo (Tree Star)
software.
Immunofluorescent Labeling.

Author Manuscript

Tissues were dissected from euthanized animals and fixed overnight in 4%
paraformaldehyde (PFA) at 4°C. For analysis by IF, fixed tissues were placed in 30%
sucrose solution for 24 hours and subsequently frozen in OCT. Bones were decalcified in
0.5M EDTA solution (Fisher Scientific) for 6 days at 4°C, placed in 30% sucrose solution
for 24 hours at 4°C, and frozen in OCT. BM 6–8 mm cryostat sections were dried at RT
overnight in the dark, rehydrated and stained with anti-RFP (1:200) (Abcam) antibody at
4°C overnight. For osteo populations IF, primary antibodies against murine Mmp14 (Abcam,
ab78738, 1:100), Cd9 (BosterBio, M01202, 1:50), or Car3 (Abcam, ab118428, 1:100),
CD63-APC (NVG2), CD200-APC (0X90) were added and incubated in a wet dark chamber
overnight at 4°C. For vascular and perivascular populations the following antibodies were
used: Endomucin (Santa Cruz, V.7C7, 1:100), CD31 (R&D, 1:100), Laminin (Abcam,
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1:100), Sca-1 (BioLegend, 1:100), Icam2 (BD Pharmingen, 1:100), Podocalyxin (R & D,
1:100), VEGFR3(R & D, 1:100), ICAM1 (BioLegend,1:100), ESM1 (R&D, 1:100), CD200
(Biolegend, 0X90, 1:100), CD63 (Biolegend, NVG2, 1:100). When indicated, the sections
were stained with DAPI for 5 min and mounted with Fluoromount-G (Southern Biotech).
Images were taken using Leica TCSSP5 II Confocal Microscope and analyzed on Leica
Microsystems imaging software.

Author Manuscript
Author Manuscript

For, early progenitors (Lin−CD48−CD150+) progenitors imaging, mDll4-mCherry animals
were anesthetized and injected with 25ug BV13 (Biolegend) conjugated to Alexa Fluor 647
(Life Technologies). After 10 minutes, mice were euthanized according to IACUC protocol.
Long bones were freshly isolated and decalcified in 10% EDTA for 72 hrs at room
temperature. Bones were cryopreserved in 30% Sucrose for 48 hrs at 4°C and then
embedded in a 50% O.C.T. (Tissue-Tek) and 50% (30%) Sucrose mixture and placed on a
liquid nitrogen bath. Bones were then sectioned on a Leica CM 3050 S cryostat in 12micron slices and collected on slides using the Leica CryoJane tape-transfer method. Slides
were brought to room temperature and immersed in a blocking solution (10% Normal Goat
Serum [Jackson Laboratories], 0.1% Triton X-100) for 30 minutes at room temperature,
protected from light. Blocking solution was removed and sections were immersed in desired
primary conjugated antibody combinations diluted in blocking and incubated overnight at
4°C. The following antibodies were used for staining: Lineage (Ter119 (Biolegend, Ter119,
1:100), CD41 (Biolegend, MWReG30, 1:100), CD11b (Biolegend, M1/70, 1:100), Gr1
(Biolegend, RB6–8C5, 1:100), B220 (Biolegend, RA3– 6B2, 1:100), CD48 (Biolegend,
HM48–1, 1:100), CD150 (Biolegend, TC15–12F12.2, 1:100)). Sections were washed and
immersed in desired secondary antibodies in blocking solution for 30 minutes at room
temperature. Slides were washed and counterstained with DAPI (1:5000, Biolegend) for 10
minutes at room temperature. Slides were washed, mounted with Prolong Gold (Life
Technologies) anti-fade solution and cover slipped for imaging. Images were taken on a
Nikon C2 confocal laser scanning microscope.
Intravital BM imaging.
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Mice were anesthetized using isoflurane and secured on a warming imaging plate in a supine
position. The medial or soleus region of the tibia was surgically exposed removing soft
tissue. The bone was carefully thinned using a microdrill. Exposed tibia was mounted and
immobilized with a metal plate, with an imaging window. All images were collected on an
Olympus FV-1000MPE upright laser scanning microscope with a 25X 1.05 NA water
immersion objective using a Spectra-physics DeepSee-MaiTai Ti:sapphire pulsed laser for
excitation, with emission filters for the detection of second harmonic (compact bone), FITC
(GFP), rhodamine (Tomato or DsRed fluorescent proteins) and qdot 705 (Invitrogen). To
visualize mCherry expression, Ti-Sapphire laser excitation was tuned to 740nm and
emission collected by non-descanned PMT using a 595–645nm filterset.
CFU-F assay.
1 × 103 sorted cells were seeded per well in a 6-well adherent tissue culture plate using
phenol red–free alpha-MEM (Gibco) media supplemented with 15% FBS (Gibco), 10%
MesenCult stimulatory supplement (STEMCELL Technologies), and 0.5% penicillin-
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streptomycin. One half of the media was replaced after 7 days and at day 14 cells were
stained with Giemsa staining kit (EMD Chemicals) and colonies counted.
RNA extraction and population-based RNA-seq.

Author Manuscript

Total RNA was extracted from samples using RNeasy Plus Micro Kit (Life Technologies).
Libraries were generated with SMART-Seq® v4 Ultra™ Low Input RNA Kit for Sequencing
and Low Input Library Prep Kit v2 (Takara Bio #634899). Libraries were sequenced on an
Illumina HiSeq 4000 sequencer. Sequencing results were demultiplexed and converted to
FASTQ format using Illumina bcl2fastq software. The sequencing reads were aligned to the
mouse genome (mm10/GRCm38) using the splice-aware STAR aligner59. The
featureCounts program60 was utilized to generate counts for each gene based on how many
aligned reads overlap its exons. These counts were then normalized and used to test for
differential expression using negative binomial generalized linear models implemented by
the DESeq2 R package61.
Single-cell library preparation and sequencing.
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For scRNA-seq libraries we sorted the following cellular subsets: VEcad-tdT (pooled n=3
animals, 12w), Lepr-tdT (pooled n=2; 12w), and Col2.3-tdT (pooled n=3; 16w); PBS-treated
VEcad-tdT (pooled n=5 animals, 6 and 14w), Lepr-tdT (pooled n=2; 18 and 22w), and
Col2.3-tdT (pooled n=3; 5 and14w); and 5-FU-treated VEcad-tdT (pooled n=14 animals;
14w), Lepr-tdT (pooled n=4, 18 and 22w ), and Col2.3-tdT (pooled n=3; 5 and 14w). For the
replicate scRNA-seq experiments the following cellular subsets were sorted: PBS-treated
VEcad-tdT (pooled n=3 animals, 9w), Lepr-tdT (pooled n=2; 7w) and 5-FU treated VEcadtdT (pooled n=4 animals; 9w), Lepr-tdT (pooled n=3, 7w). The libraries were prepared using
the Single Cell 3’ Reagent Kits v2: Chromium™ Single Cell 3’ Library & Gel Bead Kit v2,
PN-120237; Single Cell 3’ Chip Kit v2 PN-120236 and i7 Multiplex Kit PN-120262” (10x
Genomics)62, and following the Single Cell 3’ Reagent Kits v2 User Guide (Manual Part #
CG00052 Rev A). Libraries were run on an Illumina HiSeq 4000 as 150 bp paired-end
reads, one full lane per sample. We generated eight total libraries for the original set of
experiments (Figs. 1–3) and four additional libraries for the validation experiments
(Extended Data Fig. 7). In the first set of the experiments three libraries were generated
using untreated animals, two libraries were generated using animals treated with PBS, and
three libraries were generated upon treatment with 5-FU. For the second set of the
experiments two libraries were using animals treated with PBS and libraries were generated
upon treatment with 5-FU.
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For LSK scRNA-seq libraries, control and VEc-Dll4i3COIN animals were treated with
tamoxifen to induce Dll4 deletion as described, and allowed to recover for two weeks. Next,
LSKs (Lineage−Sca-1+CD117+) from littermate control (pooled n=2; 10w) and VEcDll4i3COIN (pooled n=2; 10w) were sorted on FACSAria™ II and libraries prepared as
described.
scRNA-Seq data pre-processing.
Sequencing results were demultiplexed and converted to FASTQ format using Illumina
bcl2fastq software. The Cell Ranger Single-Cell Software Suite (https://support.
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10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/what-is-cell-ranger)
was used to perform sample demultiplexing, barcode processing, and single-cell 3’ gene
counting. The cDNA insert was aligned to the mm10/GRCm38 reference genome. Only
confidently mapped, non-PCR duplicates with valid barcodes and UMIs were used to
generate the gene-barcode matrix containing 20,097 cells. Further analysis including quality
filtering, the identification of highly variable genes, dimensionality reduction, standard
unsupervised clustering algorithms, and the discovery of differentially expressed genes was
performed using the Seurat R package63. To exclude low quality cells, we removed 1,064
cells with fewer than 1,000 detected genes. To exclude cells that were extreme outliers in
terms of library complexity and may possibly include multiple cells or doublets, we
calculated the of the distribution of genes detected per cell and removing any cells in the top
2% quantile. We also removed cells with more than 10% of the transcripts coming from
mitochondrial genes. After quality filtering, the mean and median number of detected genes
per cell was 2227.2 and 1999.0, respectively. After removing unwanted cells from the
dataset, we normalized the data by the total expression, multiplied by a scale factor of
10,000, and log-transformed the result.
Integrated analysis of single cell datasets.
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To account for batch differences, we utilized the Seurat alignment method for data
integration13 which does not expect that confounding variables have uniform effects on all
cells in a dataset and allows for global transcriptional shifts between datasets. It uses a
variant of canonical correlation analysis (CCA) to find linear combinations of features and
identifies shared correlation structures across datasets13,64,65. For each dataset, we identified
variable genes while controlling for the strong relationship between variability and average
expression. We took the union of the top 2,000 genes with the highest dispersion from both
datasets and ran CCA to determine the common sources of variation between the two
datasets. We then aligned the subspaces based on the first 30 canonical correlation vectors,
generating a new dimensional reduction that was used for further analysis.
Visualization and clustering.
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To visualize the data, we further reduced the dimensionality of the entire 18,339 cell dataset
to project the cells in two-dimensional space using t-distributed Stochastic Neighbor
Embedding (tSNE) based on the aligned CCA. Aligned CCA was also used as a basis for
partitioning the dataset into clusters using a shared nearest neighbor (SNN) modularity
optimization algorithm. Based on the expression levels of the three main population markers
(Cdh5, Lepr, Col1a1), the three populations formed visually distinct clusters. However, we
also noticed small clusters of contaminating cells expressing hematopoietic markers such as
Ptprc (n=762). These were removed and the clustering process was repeated. As expected,
the cells separated into clearly distinct populations corresponding to the expression levels of
the three main population markers (Cdh5, Lepr, Col1a1) (Fig. 1b, Extended Data Fig. 1e).
Using graph-based clustering, we divided the cells into 17 transcriptionally-similar
subpopulations. We merged clusters with less than 50 steady state cells with the most
biologically similar clusters and removed two small clusters that could not be merged based
on biological identity, but were composed of too few cells to represent a real sub-population.
The resulting 17,374 cells were divided into 11 clusters (Fig. 3b). We then separated steady
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state (n=9,622) and 5-FU treated cells (n=7,752) (Fig. 3a) to initially examine the
transcriptional profile at steady state and then in the context of 5-FU treatment.
Determining cluster markers.

Author Manuscript

To find markers that define individual clusters, we performed pair-wise differential
expression analysis using the Model-based Analysis of Single-cell Transcriptomics (MAST)
method66, adjusting for cellular detection rate, for each cluster against all other clusters for
autosomal genes detected in at least 20% of the cluster cells, keeping the genes that were
significant in each of the comparisons. To visualize how well the resulting gene signatures
define the clusters, we randomly subsampled 100 cells from each cluster to neutralize size
differences and used the 10 most significant positive markers for heatmap visualization (Fig.
1c), highlighting the variation between sub-clusters within the three major BM niche
populations. To reduce the effects of distant niche elements, we additionally recalculated
cluster markers relative to only other clusters of the same population (Fig. 2 a–c).
To determine differentially expressed genes in response to 5-FU treatment, we used the
genes detected in at least 10% of either group and fold change difference of at least 10%.
Significance was determined using the MAST method with Bonferroni multiple-comparison
correction.
Independent analysis of single cell datasets.
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We repeated the analysis of the VEcad+, LepR+, and Col2.3+ steady state subsets separately.
After quality filtering, we retained 10,339 steady state cells. The mean and median number
of detected genes per cell were 1884.9 and 1680.0, respectively. We further reduced the
dimensionality of the steady state cell dataset and the first 40 principal components were
used to partition the dataset into sufficiently distinct 15 clusters. Contaminating
hematopoietic cells (n=607) were identified based on the expression of markers such as
Ptprc and removed. The three populations formed visually distinct clusters and the mixed
library was assigned to the appropriate subset based on the expression levels of the
population markers (Cdh5 and Lepr). The purified populations were then separated for
independent analysis. To account for batch differences when combining the untreated and
PBS-treated experiments, we again utilized the Seurat CCA-based alignment method. We
aligned the subspaces based on the first 10 canonical correlation vectors VEcad+ and LepR+
subsets and 15 for Col2.3+. We then applied the same approach as in the integrated analysis
for determining subpopulations and defining cluster markers. The VEcad+ cells were divided
into three clusters (Extended Data Fig. 2b). The initial analysis LepR+ cells based on six
clusters revealed a small cluster of VEcad+ cells (n=99) which was removed. Three of the
remaining clusters were merged due to their transcriptional similarity (Extended Data Fig.
2e). The Col2.3+ cells were divided into six clusters (Extended Data Fig. 2h).
Validation of 5-FU treatment in single cell datasets.
Additional VEcad+ and LepR+ PBS/5-FU treated scRNA-seq libraries were processed
following the same protocol as the original experiment. After quality filtering, we retained
18,747 cells. The mean and median number of detected genes per cell were 2390.7 and
2217.0, respectively. We further reduced the dimensionality of the steady state cell dataset
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and the first 40 principal components were used to partition the dataset into 10 clusters.
Contaminating hematopoietic cells (n=475) were identified based on the expression of
markers such as Ptprc and removed. The cells were then summarized based on the four
known populations (Extended Data Fig. 7).
LSK scRNA-seq.
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To exclude low quality cells and possible multiplets, we calculated the distribution of the
numbers of genes detected per cell and removed any cells in the top and bottom 2%
quantiles. We additionally removed cells with more than 10% of the transcripts coming from
mitochondrial genes. After filtering, the mean and median number of detected genes per cell
was 2353.5 and 2231, respectively. We normalized the data by the total expression,
multiplied this by a scale factor of 10,000, and log-transformed the result. To account for
batch differences, we utilized the Seurat CCA-based alignment method. For each dataset, we
took the union of the top 1,000 genes with the highest dispersion from both datasets and ran
a CCA to determine the common sources of variation between the two datasets. We then
aligned the subspaces based on the first 25 canonical correlation vectors, generating a new
dimensional reduction that was used for further analysis. Aligned CCA was used as a basis
for tSNE visualization and partitioning the dataset into clusters. To visualize the data, we
further reduced the dimensionality of the entire 22,022 cell dataset to project the cells in
two-dimensional space using tSNE based on the aligned CCA. Based on the initial
clustering, we were able to identify small populations of contaminating cells expressing
established lineage markers (Vpreb1, Ccl5, Ltf, Pf4, Cd74 and Carl)47 (n=906). These were
removed and the tSNE was recalculated for the remaining 21,116 cells (Fig. 5d).
Signature-based cell classification.
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To classify the cells, we used previously identified gene signatures for HSPC
compartments46. Population-specific signatures were defined by top 100 genes ranked by the
Significance Analysis of Microarrays (SAM) scores. We calculated a module score for each
cell based on the average expression levels of every gene signature, subtracted by the
aggregated expression of randomly selected control genes67. Each cell was assigned to the
population with the highest positive score (Fig. 5e). The same scoring approach was used to
quantify lineage-specific skewing (Extended Data Fig. 9k, l) and MSC enrichment
(Extended Data Fig. 4d). To confirm the identified HSPC subsets, we performed pair-wise
differential expression analysis using the MAST method to determine the populationspecific markers.
Reconstructing cell development trajectories.
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To infer the developmental progression of cells across multiple developmental stages and
order them in pseudotime, we used the algorithms implemented in the Monocle package68.
We subset the dataset to only the 4,883 P1, P2, P3, P4, O1, O2, O3 cells for the analysis. We
then identified genes that differ between the clusters based on a likelihood ratio test between
a generalized linear model that knows the cell clusters and a model that doesn’t. We then
selected the top 1,000 significantly differentially expressed genes as the ordering genes for
the trajectory reconstruction using the nonlinear reconstruction algorithm DDRTree (Fig.
2d).
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Statistical analysis and visualization of gene sets were performed using the clusterProfiler R
package69 for the genes that were calculated to be cluster markers for the cycling cluster (C)
(Extended Data Fig. 5f). Enrichr70 and WikiPathways cell signaling pathways database were
used to determine the enrichment of biological processes based on the genes that were
significant upregulated in response to 5-FU treatment in the LepR+ population (Extended
Data Fig. 6f).
qRT-PCR.
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Total RNA was extracted from samples using RNeasy Plus Micro Kit (Life Technologies)
and cDNA was prepared using the High-Capacity RNA-to-DNA Kit (Applied Biosystems).
Real time PCR reactions were carried out using TaqMan Gene Expression Master Mix (Life
Technologies) and run on a Lightcycler 480 II (Roche). The following genes were analysed
with TaqMan Gene Expression Assays: Gapdh (Mm99999915_g1), Dll4 (Mm00444619),
Dll1 (Mm01279269_m1), Jag1 (Mm00496902_m1), Cdh5 (Mm00486938_m1), Lepr
(Mm00440181_m1), Col1a1 (Mm00801666_g1).
Statistical Analysis.
Statistical analysis (excluding RNA-seq experiments) was conducted using the PRISM
program (GraphPad). Two groups were compared using an unpaired t test. To assess the
statistical significance of differences between more than two treatments, we used two-way
ANOVA. Significance was defined as *p < 0.05, **p < 0.01, *** p < 0.001.
Data availability
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The raw sequencing data and expression-count data are deposited in GEO, accession number
GSE108892. An interactive query and visualization tool for different BM niche populations
is also available at http://aifantislab.com/niche. Online Content Methods, along with any
additional Extended Data display items and Source Data, are available in the online version
of the paper; references unique to these sections appear only in the online paper.
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Extended Data Figure 1:

RNA-seq analysis of the bone marrow microenvironment populations.
a, Representative two-photon imaging of tdTomato+ vascular cells (VE-Cad—tdTomato+),
perivascular cells (LEPR—tdTomato+) and osteoblasts (COL2.3—tdTomato+). b,
Representative flow cytometry of VE-Cad-tdTomato+, LEPR-tdTomato+ and COL2.3tdTomato+ populations. c, Principal component analysis of vascular (VE-Cad-tdTomato+, n
= 4) (red), perivascular LEPR+ (LEPR-tdTomato+, n = 4) (purple) and osteoblast (COL2.3tdTomato+, n = 4) (blue) populations, based on the expression of the 1,000 most-variable
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genes in bulk RNA-seq. d, Relative expression levels of COL2.3+, LEPR+and VE-Cad+
signature genes across the three subpopulations of the bone marrow niche in bulk RNA-seq.
Normalization and statistical analysis were performed using the DESeq2 R package. e,
Normalized expression levels of the population-specific markers VE-Cad (Cdh5), LEPR
(Lepr) and COL2.3 (Col1a1) for all scRNA-seq clusters. n = 9,622 cells. The data are mean
± s.e.m. Experiments were repeated independently on more than 10 (a, b) biological samples
with similar results.
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Extended Data Figure 2:

Analysis of VE-Cad+, LEPR+ and COL2.3+populations.
a, Schematic workflow of independent and integrated analysis of VE-Cad+, LEPR+ and
COL2.3+ scRNA-seq data. b, t-SNE representation of VE-Cad+ populations only. Cluster C1
corresponds to arterial cluster V1 (Ly6ahigh). Cluster C2 corresponds to sinusoidal cluster
V2 (Stab2high). Cluster C3 is the cycling cluster. c, Normalized expression of arterial,
sinusoidal and cycling markers (Ly6a, Stab2 and Mki67, respectively) (n = 4,551 cells). d,
Gene signatures of VE-Cad+subpopulations in the bone marrow, based on the relative
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expression levels of the ten most-significant markers for each cluster. e, t-SNE
representation of the LEPR+ population only. Cluster C1 corresponds to the adipocyticprimed cluster P1 (Mgphigh) and encompasses cluster P2. Cluster C2 corresponds to P3
(Wif1high), and C3 to P4 (Spp1high). f, Normalized expression of P1, P3 and P4 markers
(Mgp, Wif1 and Spp1, respectively). n = 3,907 cells. g, Gene signatures of LEPR
+subpopulations in the bone marrow, based on the relative expression levels of the ten mostsignificant markers for each cluster. h, t-SNE representation of the COL2.3+ population
only. Cluster C1 corresponds to cluster O1 (Col16a1high), cluster C2 to O2 (Fbn1high) and
C3 to O3 (Bglaphigh). i, Normalized expression of O1, O2 and O3 markers (Col16a1, Fbn1
and Bglap, respectively). n = 1,114 cells. j, Gene signatures of COL2.3+ subpopulations in
the bone marrow, based on the relative expression levels of the ten most-significant markers
for each cluster. Cluster C4 represents arterial vascular cells (Cdh5, Kdr and Ly6e); C5 is
glial-like cells (Fabp7, Mpz and Endrb); and C6 is myocyte-like cells (Pgf, Pln and Acta2).
The data shown in c, f, i are mean ± s.e.m. MAST with Bonferroni correction (d, g, j).
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Extended Data Figure 3:
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Characterization of VE-Cad+ subpopulations.
a, Relative average scRNA-seq expression levels of the previously described arterial and
sinusoidal gene signatures at a steady state, within the VE-Cad+ clusters V1 and V2. b,
Average scRNA-seq expression levels (left) (n = 4,669 cells) and bone marrow
immunofluorescence (right) of arterial expression of SCA-1 (Ly6a), CD102 (Icam2) and
PODXL (Podxl) (n = 3 mice); LAMA1 staining (blue) labels all bone vessels; yellow
arrowheads indicate arterial vessels. Dashed lines mark bone marrow (bm), compact bone
(cb), growth plate (gp) and metaphyseal (mp) bone regions. c, Bone marrow
immunofluorescence of arterioles co-stained with SCA-1 and PODXL. n = 3 mice. d,
Average scRNA-seq expression levels (left) and bone marrow immunofluorescence (right) of
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sinusoidal VEGFR3 (Flt4) (red) and CD54 (Icam1) (green) markers. n = 3 mice. LAMA1
staining (blue) labels all bone vessels. e, Average scRNA-seq expression levels and
representative flow cytometry analysis of the arterial subpopulation (V1) using SCA-1 and
scRNA-seq-identified LY6C (Ly6c1) and CD34 (Cd34) from VE-Cad–tdTomato bone
marrow (n = 3 mice). Cells were pre-gated on DAPI−tdTomatohigh cells. The data in b, d,
eare mean ± s.e.m.
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Characterization of perivascular LepR+ subpopulations.
a, Relative average scRNA-seq expression levels of the adipocytic(Hp, Lpl, Adipoq, Slc1a5,
Cd302, Gas6 and Apoe) and osteo-associated (Ibsp, Spp1, Alpl, Wif1, Bglap, Sp7 and
Runx2)genes, as well as markers used for characterization of LEPR+ cell (Esm1, Vcam1,
Cd200 and Cd63). b, ESM1 (green) bone marrow immunofluorescence of LEPR-tdTomato
femur. LAMA1 staining (blue) labels all bone vessels. Yellow arrowhead, LEPR+ESM1+
cells; white arrowheads indicate LEPR+ESM1− cells. c, CD200 (green) and CD63 (red)
bone marrow immunofluorescence of LEPR-tdTomato femur. Nuclei, DAPI (blue). Yellow
arrowhead, LEPR+, CD200+, CD63+ cells; white arrowhead, LEPR+, CD200−, CD63− cells.
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d Human mesenchymal stem cell (hMSC) gene signature module score, overlaid on t-SNE
representation (n=9,622 cells). e, Flow cytometry representation of VCAM1highCD63low and
VCAM1lowCd63high cells of tdTomato+ subpopulations in LEPR-tdT bone marrow. Cells
were pre-gated on DAPI− tdTomatohigh cells. f, Fibroblastic colony-forming unit activity of
sorted total LEPR+ (purple), LEPR+VCAM1lowCD63high (maroon), and LEPR
+VCAM1highCD63low (yellow) cells from bone marrow of LEPR-tdTomato mice (n=8).The
data are mean ± s.d. (f). N.S., not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (Student’
t-test, two-tailed (f). Data are representative of two (b, c) or three (e, f) independent
experiments.
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Extended Data Figure 5:
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Characterization of Col2.3+ subpopulations and cycling cells.
a, Relative average scRNA-seq expression levels of O1 (Edil3, Mmp14, Ostn, Col121,
Angptl2 and Col16a1), O2- (Sox9, Comp, Chad and Col10a1), and O3- (Col11a2, Col1a2,
Sparc, Bglap2 and Bglap3) associated genes. b-d, Average scRNA-seq expression levels (n
= 9,622 cells) and bone marrow immunofluorescence of MMP14 (green) (b) (n = 3 mice),
CD9 (green) (c) (n = 3 mice) and CAR3 (green) (d) (n = 3 mice) in Col2.3-tdTomato femur,
with arrows indicating co-staining with tdTomato (red). Nuclei, DAPI (blue). Arrowhead,
Col2.3+MMP14+ (b), COL2.3+CD9+ (c), and COL2.3+CAR3+ (d). e, Expression levels of
Mki67 in all identified subpopulations (n = 9,622 cells). f, Enriched Gene ontology
biological processes terms most-strongly associated with cycling cluster (C), color-coded by
significance of enrichment and size on the basis of the fraction of overlapping genes. n =
9,622 cells. g, Contribution of VE-cad-tdTomato+, LEPR-tdTomato+, and COL2.3-tdTomato
+ cells to the cycling cluster (C) at steady state n = 70 cells. The data b-e are mean ± s.e.m
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Extended Data Figure 6:

Author Manuscript

Effect of treatment with 5-FU on subsets of the bone marrow niche.
a, Representative hematoxylin and eosin-stained sections of BM on day 5 following control
or 5-FU treatment (n = 3 animals). b, Frequency and numbers of BM LSK cells on day 5
following control (CNTRL) (n = 4) or 5-FU treatment (n = 5). c, Absolute numbers of BM
niche cells, vascular VEcad+ (CNTRL: n = 4; 5-FU: n = 10), perivascular LepR+ (CNTRL: n
= 2; 5-FU: n = 5), and Col2.3+ osteoblasts (CNTRL: n = 4; 5-FU: n = 5) from control (PBS)
and 5-FU treated animals. d, Gene signatures of niche LepR+ sub-populations, including
cluster P5, based on the average relative expression levels of the 10 most significant markers
for each cluster exclusively within the LepR+ subset. MAST with Bonferroni correction. e,
Relative expression levels of upregulated adipogenesis-associated genes and downregulated
osteogenesis-associated genes in LepR+ subpopulations in response to 5-FU treatment. f,
LepR+ cells enriched pathways in response to 5-FU treatment (n = 17,374 cells). Fisher
exact test. g, Contribution of VEcad-tdT+, Lepr-tdT+, and Col2.3-tdT+ cells to cycling
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cluster (C) following 5-FU treatment (n = 418 cells). h, Expression levels of Mki67 in all
identified subpopulations at steady state and following 5-FU (n = 17,374 cells). Data are
mean ± s.d. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (Student’s t-test, two-tailed) (b-c). The data
(h) are mean ± standard error.
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Extended Data Figure 7: Validation of scRNA-seq in VE-Cad+ and LEPR+cells following
treatment.

a, b, Heat map and hierarchical clustering of mean normalized expression values of VE-Cad
(a) and LEPR+ (b) control-treated and 5-FU-treated samples for 5-FU-modulated genes
(top 50 differentially expressed) in two independent scRNA-seq experiments. c, d, logtransformed fold changes of differentially expressed genes (up- and downregulated > 1.2×,
adjusted P value < 0.001) in 5-FU-treated versus control-treated VE-Cad+ (n = 697 genes)
cells (c) and LEPR+ (n = 829 genes) cells (d), for two independent experiments. The trend

+
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line (dashed) and the confidence interval (grey shading) were calculated using the linear
model. MAST with Bonferroni correction. VE-Cad+ control-treated, n = 5,796 cells; VECad+ 5-FU-treated, n = 1,481 cells; LEPR+ control-treated, n = 6,128 cells; LEPR+ 5-FUtreated, n = 4,867 cells.
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Extended Data Figure 8: Analysis of Dll4-mCherry, Dll1-mCherry, and Jag1-mCherry reporter
animals.

a, Reverse-transcription PCR of Dll4, Dll1 and Jag1 in vascular cells (red), perivascular
LEPR+ cells (purple) and osteoblasts (blue), normalized to Gapdh (n = 4 mice). b, Lowmagnification immunofluorescence images of thymus sections from Dll4-mCherry, Dll1mCherry and Jag1-mCherry mice. c, Representative flow cytometry, measuring mCherry
fluorescence in total bone marrow of Dll4-mCherry, Dll1-mCherry and JAG1-mCherry
mice. Indicated values represent percentages of the complete CD144+ and mCherry+CD144−

Nature. Author manuscript; available in PMC 2019 November 01.

Tikhonova et al.

Page 30

Author Manuscript

populations. Cells were pre-gated on DAPI− cells. d, Representative mCherry levels in DAPI
−CD45lowTER119lowCD144+ bone marrow endothelial cells from Dll4-mCherry (red) (n =
4), Dll1-mCherry(blue) (n = 3), Jag1-mCherry (black) (n = 4) and control (grey) (n = 5)
mice. e, f, Representative immunofluorescence metaphysis and diaphysis of Dll4-mCherry
(e) and Dll1-mCherry (f) bone marrow (n = 3 mice). mCherry (red) and LAMA1 (blue). g,
h, Representative two-photon images of bone marrow from intact (left) or dextran-injected
(right) Dll4-mCherry(g) and Dll1-mCherry (h) mice (n = 3 mice). i, Normalized counts of
key differentially expressed genes from bulk RNA-seq performed on CD144−DLL1+ cells
(purple) (from n = 2 mice) and CD144+DLL1+ cells (black) (from n = 2 mice). j,
Representative flow cytometry histogram measuring mCherry fluorescence in NK1.1+
population from Dll1-mCherry (pink) and control (black) mice (n = 3 mice). The data are
mean ± s.d. N.S., not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, Student’s t-test, twotailed. Data are representative of two (a, e–h, j) or three (b–d) independent experiments.
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Extended Data Figure 9: Gene expression program of myeloid differentiation is enhanced in VECad-Dll4i3COIN HSPCs.
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a, b, Representative percentage of bone marrow progenitors in VE-CadcreER-Dll4i3COIN and
littermate-control mice for common lymphoid progenitors gate (CLP gate) (control, n = 10;
VE-CadcreER-Dll4i3COIN, n = 11) (a) and granulocyte–monocyte progenitors gate (GMP
gate) (control, n = 10; VE-CadcreER-Dll4i3COIN, n = 13) (b). c, Frequencies of CD3+ T cells
(control, n = 12; VE-CadcreER-Dll4i3COIN, n = 11). d, Total numbers of mature
haematopoietic subsets in tamoxifen-treated VE-CadcreER-Dll4i3COIN and littermate-control
mice, including B220+ B cells (control, n = 10; VE-CadcreER-Dll4i3COIN, n = 10), CD3+ T
cells (control, n = 10; VE-CadcreER-Dll4i3COIN, n = 10) and CD11b+GR1+ myeloid cells
(control, n = 10; VE-CadcreER-Dll4i3COIN, n = 10). e, Absolute numbers of thymocytes from
VE-CadcreER-Dll4i3COIN mice (n = 11) and littermate-control mice (n = 9). f, Representative
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flow cytometry analysis of thymic subsets in tamoxifen-treated VE-CadcreER-Dll4i3COIN and
littermate-control mice. g, Frequencies (control, n = 8; VE-CadcreER-Dll4i3COIN, n = 5) and
absolute numbers (control, n = 6; VE-CadcreER-Dll4i3COIN, n = 4) of early thymic
progenitors in thymi from VE-CadcreER-Dll4i3COIN and littermate-control mice. h,
Percentage (control, n = 10; VE-CadcreER-Dll4i3COIN, n = 10) of HSCs, MPP2 cells, MPP3–
4 cells, MPP4 cells and LSK cells from the bone marrow of VE-CadcreER-Dll4i3COIN and
littermate-control mice. i, Total numbers of bone marrow HSCs, MPP2 cells, MPP3 cells,
MPP4 cells and LSK cells from VE-CadcreER-Dll4i3COIN and littermate-control mice
(control, n = 10; VE-CadcreER-Dll4i3COIN, n = 10). j, Representative immunofluorescence of
early progenitors (Lin−CD48−CD150+) adjacent to the DLL4-producing vascular
endothelium in Dll4-mCherry. Lin cocktail, CD11b, GR1, CD41, TER119 and B220.
Arrowhead, Lin−CD150+ progenitors. n = 3 mice. k, scRNA-seq t-SNE visualization of the
LSK compartment (n = 21,116 cells), colour-coded by genotype. l, m, Distribution of
enrichment scores for myeloid progenitor (l) and HSC (m) gene signatures within the
scRNA-seq-profiled HSPC populations from bone marrow of tamoxifen-treated VECadcreER-Dll4i3COIN mice (pooled n = 2) and littermate-control mice (pooled n = 2). n =
21,116 cells. The data are mean ± s.d. NS, not significant, *P ≤ 0.05, **P ≤ 0.01, ***P ≤
0.001, Student’s t-test, two-tailed (a–d, g–i) or Wilcoxon rank-sum test (l, m). Data are
representative of four (a–e) or two (g) independent experiments.
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Extended Data Figure 10: Deletion of endothelial Dll1 does not affect early lineage priming of
haematopoietic progenitors.
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a–f, Flow cytometry analysis of bone marrow progenitors in VE-Cad-Dll1fl/fl and littermatecontrol mice, showing equivalent frequencies of common lymphoid progenitors (control, n =
10; VE-Cad-Dll1fl/fl, n = 8) (a), granulocyte–monocyte progenitors (control, n = 7; VE-CadDll1fl/fl, n = 9) (b) and MPP4 cells (control, n = 10; VE-Cad-Dll1fl/fl, n = 10) (c), of B220+
B cells (control, n = 10; VE-Cad-Dll1fl/fl, n = 10) (d, f), CD3+ T cells (control, n = 10; VECad-Dll1fl/fl, n = 10) (d, f) and CD11b+GR1+ monocytic–granulocytic subset (control, n = 8;
VE-Cad-Dll1fl/fl, n = 9) (e, f). g, Absolute numbers of thymocytes from VE-Cad-Dll1fl/fl and
littermate-control mice (control, n = 6; VE-Cad-Dll1fl/fl, n = 10). h, Representative flow
cytometry analysis of thymic subsets in VE-Cad-Dll1fl/fl and littermate-control mice. i,
Frequencies (control, n = 4; VE-Cad-Dll1fl/fl, n = 6) and absolute numbers (control, n = 4;
VE-Cad-Dll1fl/fl, n = 6) of early thymic progenitors from thymi of VE-Cad-Dll1fl/fl and
littermate-control mice. The data are mean ± s.d. N.S., not significant, Student’s t-test, twotailed. Data are representative of three independent experiments.
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Figure 1: Single-cell RNA-sequencing analysis of the BM microenvironment at steady state.
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a, Schematic representation of BM niche: osteoblasts (Col2.3+, blue), perivascular LepR+
(LepR+, purple), and vascular cells (VEcad+, red). b. Expression levels of genes associated
with niche-specific Cre strains, including Cdh5 (VE-cadherin), Lepr (Leptin receptor) and
Col1a1 (Col2.3) overlaid on tSNE representation (n=9,622 cells). Dashed lines generally
encompass the cells profiled in Col2.3+, LepR+, VEcad+ libraries. c, Gene signatures of
VEcad+, LepR+, and Col2.3+ sub-populations based on the relative expression levels of the
10 most significant markers for each of the 10 clusters, displaying 100 randomly-selected
cells per cluster. MAST with Bonferroni correction. d, tSNE visualization of color-coded
clustering of BM niche (n=17,374 cells). Dashed lines generally encompass the examined
VEcad+ (red), LepR+ (purple), Col2.3+ (blue) BM niche populations and the cycling cells
(sea green).
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Figure 2: Expression of pro-hematopoietic factors by the BM microenvironment.
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a-c, Gene signatures of BM niche sub-populations based on the average relative expression
levels of the 10 most significant markers for each cluster exclusively within the parent niche
subsets (VEcad+ (a), LepR+(b), or Col2.3+(c)) at steady state. MAST with Bonferroni
correction. d, Reconstructed cell differentiation trajectory of LepR+ and Col2.3+ clusters
colored by subpopulation identity. e, Expression levels of indicated genes in LepR+ and
Col2.3+ cells with respect to their pseudotime coordinates. Black lines depict the LOESS fit
of the normalized expression values. f, Expression levels of pro-hematopoietic factors in the
non-cycling clusters (n=9,622 cells). The data are mean ± standard error.
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Figure 3: Single-cell transcriptome profiling of the BM niche in response to chemotherapy.

a, VEcad+ (red), LepR+ (purple), and Col2.3+ (blue) cells at steady state (dark) or following
5-FU treatment (light) overlaid on tSNE representation (n=17,374 cells). b, tSNE plot of
color-coded clusters of all examined (control and 5-FU treated) BM niche cells (n=17,374
cells). Dashed lines generally encompass the examined VEcad+ (red), LepR+(purple),
Col2.3+ (blue) BM niche populations and the cycling cells (sea green). c, Frequencies of
each sub-population within VEcad+, LepR+, and Col2.3+ compartments under the indicated
condition. d, Relative expression of pro-hematopoietic factors examined in Fig. 2e in
response to 5-FU treatment (n=17,374 cells). Adjusted *P≤ 0.05, **P≤ 0.01, ***P< 0.001
(MAST with Bonferroni correction). The data are mean ± standard error.
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Figure 4: Vascular endothelial cells are the major source of Dll4 and Dll1 in the BM.
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a, Map of BAC clones used to drive transgenes mDll4-mCherry, mDll1-mCherry, and
mJag1-mCherry. b, Representative flow cytometry histogram measuring mCherry
fluorescence in DAPI−CD45/Ter119lowCD144+ endothelial cells from BM of mDll4mCherry, mDll1-mCherry, and mJAG1-mCherry. Indicated values represent percentages of
the complete CD45/Ter119 population. c-d, Representative two photon images of BM from
dextran-injected mDll4-mCherry (c) and mDll1-mCherry (d). (c-d) Scale bars are 100 μm
and 25 μm, as indicated in the images. Data are representative of three independent
experiments (b-d).
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Figure 5: Dll4 expressed by vascular endothelial cells prevents myeloid skewing of hematopoietic
progenitors.

a-c, Representative flow cytometry (a,b) and frequencies (c) of mature hematopoietic
subsets in VEc-Dll4i3COIN and littermate control animals, including B220+ B cells (CNTRL:
n=12; VEc-Dll4i3COIN: n=11) and CD11b+Gr1+ cells (CNTRL: n=12; VEc-Dll4i3COIN:
n=11). d, LSK compartment scRNA-seq tSNE visualization (n=21,116 cells), color-coded
by the identified HSPC populations. e, Log-transformed normalized expression levels of
myeloid-associated genes (Calr, Ctsg, Elane, and Mpo) and Mki67 across HSPC populations
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in control and VEc-Dll4i3COIN LSK cells (n=21,116 cells). Violin plots depict kernel density
estimation to show the distribution of expression values. Data are mean ± s.d. *P≤ 0.05,
**P≤ 0.01, ***P≤ 0.001 (Student t-test, two-tailed (c), MAST test with Bonferroni
correction (e)). Data are representative of four (a-c) independent experiments.
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